Literature DB >> 11300610

The impact of glycaemic control on autoregulation of glomerular filtration rate in patients with non-insulin dependent diabetes.

P K Christensen1, S Lund, H H Parving.   

Abstract

UNLABELLED: The ability of the kidney to maintain constancy of glomerular filtration rate (GFR) over a wide range of renal perfusion pressures is termed autoregulation. Defective autoregulation of GFR has been demonstrated in patients with diabetic and non-diabetic nephropathy and in streptozotocin diabetic rats during hyperglycaemia. Information on the potential impact of acute changes in glycaemic control on autoregulation of GFR in diabetic patients is lacking. Therefore the aim of our study was to evaluate the effect of acute lowering of blood pressure (BP) on GFR during normoglycaemia and hyperglycaemia. We investigated 14 (12m/2f) normoalbuminuric patients with non-insulin dependent diabetes (NIDDM). The patients were examined in random order on two separate days with blood glucose (BG)<10 mmol/L or with BG>15 mmol/L. GFR (single shot [51Cr] EDTA plasma clearance technique) was measured twice each day; first without clonidine (baseline) followed by intravenous injection of clonidine 100-150 microg. We measured BG (One Touch 2), and BP (Takeda TM2420) several times during each GFR measurement. Clonidine reduced mean arterial blood pressure with 20 (1.4) vs. 16 (1.2) mmHg (mean (SE)) with BG<10mmol/L and with BG>15 mmol/L, respectively (p=0.053). GFR diminished in average from 92 (3.1) to 86 (3.7) ml/min/1.73m2 with BG<10 mmol/L (p<0.05), and from 102 (4.1) to 98 (4.2) ml/min/1.73 m2 with BG> 15 mmol/L, NS. Mean difference between changes in GFR (95% confidence interval) between the examination with BG<10 mmol/L and with BG>15 mmol/L were 2.3 (-1.3 to 5.9) ml/min/1.73 m2 (NS). The mean BG during normoglycaemia was 6.9 (0.3) vs.16.9 (0.4) during hyperglycaemia.
CONCLUSION: Our study suggests that acute changes in glycaemic control have no detectable effect on autoregulation of GFR in NIDDM patients. Hyperglycaemia enhances GFR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11300610     DOI: 10.1080/00365510151067965

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  The Chronic Kidney Disease Epidemiology Collaboration equation improves the detection of hyperfiltration in Chinese diabetic patients.

Authors:  Fangya Zhao; Lei Zhang; Junxi Lu; Kaifeng Guo; Mian Wu; Haoyong Yu; Mingliang Zhang; Yuqian Bao; Haibing Chen; Weiping Jia
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension.

Authors:  Hiroki Yokoyama; Sakiko Kanno; Suguho Takahashi; Daishiro Yamada; Hiroshi Itoh; Kazumi Saito; Hirohito Sone; Masakazu Haneda
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

4.  Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria.

Authors:  Shoichi Akazawa; Eiji Sadashima; Yasunori Sera; Nobuhiko Koga
Journal:  Diabetol Int       Date:  2021-07-29

Review 5.  Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Authors:  Clement Lo; Tadashi Toyama; Ying Wang; Jin Lin; Yoichiro Hirakawa; Min Jun; Alan Cass; Carmel M Hawley; Helen Pilmore; Sunil V Badve; Vlado Perkovic; Sophia Zoungas
Journal:  Cochrane Database Syst Rev       Date:  2018-09-24

6.  The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function.

Authors:  Richard J MacIsaac; Elif I Ekinci; Erosha Premaratne; Zhong X Lu; Jas-Mine Seah; Yue Li; Ray Boston; Glenn M Ward; George Jerums
Journal:  BMC Nephrol       Date:  2015-12-03       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.